Insurance delays in the approval of biologic medications for patients with psoriasis and psoriatic arthritis

Autor: Thomas Vazquez, Mahtab Forouzandeh, Deborah Lin, Felix Chin, Mariana Perez, Alberto Caban-Martinez, Andrea Maderal
Rok vydání: 2022
Předmět:
Zdroj: Archives of Dermatological Research.
ISSN: 1432-069X
DOI: 10.1007/s00403-022-02457-6
Popis: Biologics are the most effective treatment for moderate-to-severe psoriasis. Insurance approval and need for prior authorization continue to be a barrier to care for many patients with psoriasis and psoriatic arthritis. We sought to determine whether race/ethnicity, insurance type, and provider specialty affect biologic approval times. Records from the University of Miami Health System were reviewed, and 101 patients were included. Need for a prior authorization was significantly associated with long waits (p = 2.4 × 10
Databáze: OpenAIRE